Faricimab in previously treated nAMD: Real-World Outcomes of a No-Loading-Dose Switching Protocol.

Vabysmo (faricimab-svoa) - Roche

Lucentis (ranibizumab) - Roche, Novartis

http://www.ncbi.nlm.nih.gov/pubmed/42721102

Jonathan Rencker; Laurent Kodjikian; Nicolas Lepretre; Scott Lenhof; Thibaud Mathis

Sep 11, 2026